Evidence map›Paper›PMID 37563552›Full record

Observational studyBMC infectious diseases2023

Characteristics and treatment outcomes of co-infected tuberculosis patients with human immunodeficiency virus in Southeast China, 2012-2021.

Yinfa Zhou, Tao Li, Shufang Lin, Daiquan Chen, Yongcheng Du, Jiangfeng Chen, Kun Chen, Zhisong Dai

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yinfa ZhouDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China.
Tao LiNational Center for Tuberculosis Control and Prevention, China CDC, Beijing, 100000, China.
Shufang LinDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China.
Daiquan ChenDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China.
Yongcheng DuDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China.
Jiangfeng ChenDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China.
Kun ChenDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China.
Zhisong DaiDivision of Tuberculosis Control and Prevention, Fujian CDC, Fuzhou, 350000, China. simonwind100@126.com.
Heilongjiang Center for Tuberculosis Control and Prevention · CNChinese Center For Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) is a chronic respiratory infection. Co-infection with human immunodeficiency virus (HIV) has been a significant obstacle to TB control. Insufficient attention has been given to TB/HIV, and more information is needed to address this issue. We conducted an observational study to investigate the epidemiological characteristics, treatment outcomes and its associated factors of HIV-positive TB patients in Southeast China.

methodsAn observational study was conducted based on data collected directly from China National TB Surveillance System during 2012-2021. Epidemiological characteristics, drug resistance and outcomes were described as frequency (n) and percentage (%). Risk factors for unsuccessful outcomes were determined using univariate (chi-squared) and multivariate logistic regression analysis.

resultsA total of 347 TB/HIV cases were included, and the proportion of HIV-positive cases among all TB cases increased significantly from 0.06% to 2012 to 0.40% in 2021. The majority of cases were males (86.5%), non-local household registers (139, 40.1%), farmers or workers (179, 51.6%), and aged 40-59 (142, 40.9%). Of 347 cases, 290 (83.6%) had pulmonary TB (PTB), 10 (2.9%) had extra pulmonary TB (EPTB) and 47(13.5%) had both PTB and EPTB. A total A total of 258 (74.4%) were HIV positive prior to TB diagnosis. 8.0% (4/50) of cases were resistant to rifampicin (RIF) and 274 patients (83.8%) had successful outcomes. Being non-local (AOR = 2.193, 95% CI = 1.196-4.022, P = 0.011) and diagnosed HIV infection after TB (AOR = 2.365, 95% CI = 1.263-4.430, P = 0.007) were independent risk factors for unsuccessful outcomes of anti-TB treatment.

conclusionDuring 2012-2021, the proportion of HIV-positive cases among all TB cases increased significantly in Southeast China. HIV-positive TB patients were significantly more likely to develop resistance to RIF and INH and unsuccessful anti-TB treatment. Non-local registration and becoming HIV positive after TB diagnosis were independent risk factors associated with unsuccessful outcomes.

Indexed as

CoinfectionHIV InfectionsHIV SeropositivityTuberculosisAntitubercular AgentsChinaFemaleHIVHumansMaleRetrospective StudiesRifampinTreatment OutcomeAntitubercular AgentsRifampinCharacteristicDrug resistanceHuman immunodeficiency virus (HIV)OutcomeRisk factorTuberculosis (TB)

Identifiers

PMID37563552
PMCPMC10416501
OpenAlexW4385737783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.